Marcus Evans will host the Healthcare CEO & Executive Strategy Summit at the Red Rock Casino Resort and Spa in Las Vegas, Nevada, bringing together senior healthcare executives and select suppliers and solution providers for two days of strategic discussion, peer learning, and high-value collaboration. The Summit is invitation-only and designed as a premium forum where hospital and health system leaders can engage with content aligned to current market developments and the practical strat

DKSH entered a strategic distribution partnership with BridgeBio to support regulatory evaluation and potential patient access to a Transthyretin Stabilizer for ATTR-CM in Australia, Singapore, South Korea, and Taiwan. The partnership combines BridgeBio's biotech innovation and DKSH Healthcare's integrated end-to-end commercialization platform to bring a new treatment option to patients. DKSH Business Unit Healthcare, a strategic healthcare business partner and leading provi

Tanner Health and Healthliant Ventures announce the launch of Optellum’s Virtual Nodule Clinic® (VNC), an artificial intelligence (AI) platform designed to assist care teams in identifying, risk assessing and managing patients with potentially cancerous lung nodules. Lung cancer remains the leading cause of cancer deaths worldwide, in large part due to late diagnosis. Optellum’s lung cancer prediction (LCP) AI solution addresses this challenge by using advanced imagi

Mosaic Clinical Technologies™, a wholly owned subsidiary of Radiology Partners, today announced the commercial launch of Mosaic Reporting™, a new class of AI-native radiology reporting solution available as part of MosaicOS™. Mosaic Reporting is already deployed to thousands of radiologists through Radiology Partners-affiliated practices, giving Mosaic a scaled real-world environment to refine and expand the platform. Powered by foundation models developed by Cogni

Royal Philips a global leader in health technology, and WellSpan Health, the leading health care system in Central Pennsylvania and Northern Maryland, today announced a landmark seven-year strategic alliance that establishes a new research and innovation collaboration and brings new advanced imaging and diagnostics technology products and platforms to patients across the region. The alliance is the latest addition to WellSpan’s growing innovation ecosystem, positioning the system as a n

DocGo Inc, a leading provider of technology-enabled mobile health and medical transportation services, today announced that its PTI Health by DocGo subsidiary has launched mobile phlebotomy services in Southern Florida. In conjunction with this launch, PTI Health has expanded its relationship with a major national clinical laboratory to cover services throughout the Southeast and will work collaboratively with this lab partner to bring mobile phlebotomy service to the lab’s existing net

HeartBeam, Inc, a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced a peer-reviewed article in JACC: Advances, a journal of the American College of Cardiology, demonstrating that a risk prediction algorithm incorporating the credit card-sized HeartBeam ECG device can accurately identify heart attack risk in patients presenting with chest pain. The publication is available in the June 2026 issue and online. The art

SurGenTec, LLC, a leader in innovative spine and orthopedic technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) SurGenTec, LLC, a leader in innovative spine and orthopedic technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its ION-C™ navigation instruments for use with the ION-C™ posterior cervical facet fixation implant. The system is engineered for compatibility w

Inspirity Health Partners (IHP) has entered into a strategic, multi-year agreement with Tallahassee Memorial HealthCare (TMH) to advance and integrate TMH’s supply chain capabilities through a collaborative, high-performance partnership model. With a well-established category management structure, disciplined operational processes and strong clinical engagement, TMH joins Inspirity from a position of strength. Through this new collaboration, TMH will expand its capabilities by

Cardiosense, a healthcare technology company focused on heart failure care, today announced that the U.S. Food & Drug Administration (FDA) has granted De Novo classification for its PCWP Analysis Software™, a first-in-class technology to estimate a key indicator of heart health noninvasively. With this authorization, Cardiosense has a clear path forward in supporting clinicians who manage heart failure by providing critical data to improve therapy and avoid prolonged hospitalization